0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Hypomania Induced by Adjunctive Lamotrigine
HOWARD C. MARGOLESE, M.D., C.M., F.R.C.P.(C.); LINDA BEAUCLAIR, M.D., F.R.C.P.(C.); NADIA SZKRUMELAK, M.D., F.R.C.P.(C.); GUY CHOUINARD, M.D., M.Sc., F.R.C.P.(C.)
Am J Psychiatry 2003;160:183-a-184. doi:10.1176/appi.ajp.160.1.183-a

To the Editor: Adjunctive and monotherapeutic lamotrigine has been effective in the treatment of bipolar (14) and unipolar (3, 5) mood disorders. We present a case of potentiation with lamotrigine for major depression that was partially responsive to antidepressants, in which the patient developed hypomania. This is, to our knowledge, the first such reported case.

Ms. A was a 23-year-old woman with a DSM-IV diagnosis of major depression and no personal history of bipolar illness and no family history of mood disorders. She had a partial response to 6 months of combination cognitive therapy and buproprion, 300 mg/day. The buproprion was increased to 400 mg/day for 3 months without further improvement. Lamotrigine was then added. After 1 week of 25 mg at bedtime, Ms. A reported an improved mood. After another week at 50 mg/day, she noted a further improved mood, decreased anxiety, and increased energy. Two weeks later, her lamotrigine dose was increased to 75 mg/day. One week thereafter, she reported decreased sleep (2–4 hours per night), increased energy, distractibility, mood lability, and increased spending. She reported no grandiose or other delusions but scored 9 on the Altman Self-Rating Mania Scale (6) (a score >6 suggests hypomania or mania), and she met DSM-IV criteria for hypomania. Her lamotrigine dose was reduced to 50 mg at bedtime. Two weeks later, the hypomanic symptoms subsided (Altman Self-Rating Mania Scale score=5). Fourteen months later, Ms. A remained euthymic.

All antidepressants can induce hypomania or mania in susceptible unipolar patients when they are given in combination or at a high dose. Our patient’s hypomanic state is further evidence that lamotrigine has potentiating antidepressant properties, likely through its ability to decrease glutamate release, thereby reducing binding to the N-methyl-d-aspartate receptor complex (4). This case report supports lamotrigine’s role as an adjunctive and potentiation treatment in partially responsive unipolar depression.

Suppes T, Brown ES, McElroy SL, Keck PE Jr, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM: Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord  1999; 53:95-98
[PubMed]
[CrossRef]
 
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (Lamictal 602 Study Group): A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry  1999; 60:79-88
[PubMed]
[CrossRef]
 
Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol  2000; 20:607-614
[PubMed]
[CrossRef]
 
Sporn J, Sachs G: The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol  1997; 17:185-189
[PubMed]
[CrossRef]
 
Maltese TM: Adjunctive lamotrigine treatment for major depression (letter). Am J Psychiatry  1999; 156:1833
 
Altman EG, Hedeker D, Peterson JL, Davis JM: The Altman Self-Rating Mania Scale. Biol Psychiatry  1997; 42:948-955
[PubMed]
[CrossRef]
 
+

References

Suppes T, Brown ES, McElroy SL, Keck PE Jr, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM: Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord  1999; 53:95-98
[PubMed]
[CrossRef]
 
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (Lamictal 602 Study Group): A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry  1999; 60:79-88
[PubMed]
[CrossRef]
 
Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol  2000; 20:607-614
[PubMed]
[CrossRef]
 
Sporn J, Sachs G: The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol  1997; 17:185-189
[PubMed]
[CrossRef]
 
Maltese TM: Adjunctive lamotrigine treatment for major depression (letter). Am J Psychiatry  1999; 156:1833
 
Altman EG, Hedeker D, Peterson JL, Davis JM: The Altman Self-Rating Mania Scale. Biol Psychiatry  1997; 42:948-955
[PubMed]
[CrossRef]
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 10

Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
APA Practice Guidelines > Chapter 7.  >
APA Practice Guidelines > Chapter 0.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 39.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles